400 / 1498
Tumour control
in GHSG trials HD9, HD12, HD15
431
HD9 C
409
385
374
358
334
298
715
HD12 A+B
669
619
592
543
447
282
2012
HD15 all
1848
1560
1122
702
359
122
Pts. at Risk
PFS
0.0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
0
12
24
36
48
60
72
Months from randomization
HD9 C
HD12 A+B
HD15 all
PFS:91% at 5 years